Drug Trial Radar · NCT00031096
Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne
Last checked: Nov 19, 2026Latest source record: Jun 9, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
879
Actual
Start
Jan 2002
Primary completion
Jul 2002
Study completion Jul 2002
Sponsor
- Lead sponsor
- LEO PharmaIndustry
- Sponsor type
- Industry
- Collaborators
- Bayer
- First posted
- Feb 22, 2002
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Comparison of efficacy and safety of Azelaic Acid 15% gel with its vehicle in male and female patients with mild to moderate acne. Qualified subjects will apply the gel to their face twice a day for a period of 12 weeks. Subjects will be required to return to the doctor's office for up to 5 visits.
Conditions
- Acne Vulgaris
Interventions
Azelaic Acid Gel 15% (Finacea, BAY39-6251)Drug
Azelaic Acid 15% gel (SH H 655 BA) applied topically two times per day.
Vehicle gel (SH H 655 PBA)Drug
Vehicle gel (SH H 655 PBA) applied topically two times per day.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The nominal and percent change in lesions counts from baseline to last available visit (end of treatment) and treatment success rates based on Investigator's assessment of mild to moderate acneTime frame: 12 weeks
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Mobile, Alabama
Site not named
Boulder, Colorado
Site not named
Newnan, Georgia
Site not named
Shawnee Mission, Kansas
Site not named
Wichita, Kansas
Site not named
Lexington, Kentucky
Site not named
Albuquerque, New Mexico
Site not named
Bay Shore, New York
Site not named
Winston-Salem, North Carolina
Site not named
Cincinnati, Ohio
Site not named
Portland, Oregon
Site not named
Hershey, Pennsylvania
Site not named
Knoxville, Tennessee
Site not named
Bryan, Texas
Site not named
San Antonio, Texas
Site not named
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.